Kazia Therapeutics
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WAKazia Therapeutics Limited (KZA) is an oncology-focused biotechnology company. KZA is focused on the development of novel anti-cancer drugs based on two proprietary drug technologies known as Super-benzopyrans and Anti-tropomyosins. KZA is headquartered in Sydney, Australia, with an office in New Haven, Connecticut in the US.
Contact Details
Level 24, Three International Towers, 300 Barangaroo Ave, SYDNEY NSW 2000
02 9472 4100
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Rimfire Pacific Mining | $836k |
| 893rd | | Tryptamine Therapeutics | $3.4m |
| 894th | | Kazia Therapeutics | $3.4m |
| 1129th | | Ausmon Resources | $69k |
| 1136th | | West Wits Mining | $56k |
1332 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEW ROLE: J Friend, | 03 Nov 2022 |
| NEW ROLE: K Krumeich, | 03 Nov 2022 |
| NEWS: Tagged in Where markets meet medicine; a biotech entrepreneur at the tip of the spear | 14 Feb 2022 |
| NEW ROLE: P Leong, | 24 Nov 2020 |
| NEW ROLE: G Hirsch, | 24 Nov 2020 |
| NEW ROLE: G Heaton, Dir:Finance & Administration | 24 Nov 2020 |
| NEW ROLE: Kate Hill, Company Secretary | 24 Nov 2020 |
| NEW ROLE: Steven RS Coffey, Non-Executive Director | 03 Nov 2020 |
